global measles and rubella update june 2018€¦ · global measles and rubella update june 2018....
TRANSCRIPT
Global Measles and Rubella UpdateJune 2018
Measles
Number of Reported Measles Cases by WHO Regions
2018
RegionMember States*
Suspected cases
Measles cases
Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov DecDate
Received
AFR 42/47 21980 13648 8856 2485 2307 2903 3636 4203 2058 848 0 0 0 0 0 0 0 2018-06
AMR 29/35 5336 1209 0 0 1209 3 10 70 73 1053 0 0 0 0 0 0 0 2018-06
EMR 20/21 9818 3996 1114 257 2625 1890 785 1040 277 4 0 0 0 0 0 0 0 2018-06
EUR 51/53 23799 21478 10898 1043 9537 5564 6335 6743 2779 57 0 0 0 0 0 0 0 2018-06
SEAR 11/11 46620 32033 28506 1983 1544 6264 5736 10320 9377 336 0 0 0 0 0 0 0 2018-06
WPR 26/27 20617 9271 5783 128 3360 1850 2383 3117 1913 8 0 0 0 0 0 0 0 2018-06
Total 179/194 128170 81635 55157 5896 20582 18474 18885 25493 16477 2306 0 0 0 0 0 0 0
2017
RegionMember States*
Suspected cases
Measles cases
Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov DecDate
Received
AFR 43/47 51541 24814 10992 8836 4986 3210 2896 3642 2370 2026 1859 1475 1412 1519 1695 1315 1395 2018-06
AMR 31/35 10851 895 0 0 895 2 10 19 13 5 1 4 37 200 214 118 272 2018-06
EMR 20/21 36138 12776 1918 693 10165 1103 1080 1296 1280 1460 1057 1061 812 706 941 950 1030 2018-06
EUR 52/53 28868 22373 4347 5114 12912 1105 1871 3006 2884 2836 1560 1382 869 819 1160 2110 2771 2018-06
SEAR 11/11 97374 75362 56276 13214 5872 8688 9704 13120 10328 7530 4390 3634 4271 3388 2898 3822 3589 2018-06
WPR 26/27 53074 10524 2982 101 7441 784 899 1509 1228 1129 833 776 717 743 780 629 497 2018-06
Total 183/194 277846 146744 76515 27958 42271 14892 16460 22592 18103 14986 9700 8332 8118 7375 7688 8944 9554
Notes: Based on data received 2018-06 - This is surveillance data, hence for the last month, the data may be incomplete. * Member States
Reporting / Total Member States in Region
Measles case distribution by month and WHO Region (2014-2018)
20
14
-01
20
14
-02
20
14
-03
20
14
-04
20
14
-05
20
14
-06
20
14
-07
20
14
-08
20
14
-09
20
14
-10
20
14
-11
20
14
-12
20
15
-01
20
15
-02
20
15
-03
20
15
-04
20
15
-05
20
15
-06
20
15
-07
20
15
-08
20
15
-09
20
15
-10
20
15
-11
20
15
-12
20
16
-01
20
16
-02
20
16
-03
20
16
-04
20
16
-05
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
0
5000
10000
15000
20000
25000
30000
35000
40000
Month of onset
Mea
sles
cas
es
(Lab
+Ep
i+C
linic
al)
WPRSEAREUREMRAMRAFR
Notes: Based on data received 2018-06 - Data Source: IVB Database - This is surveillance data, hence for the last month(s), the data may be
incomplete.
Measles Incidence Rate per Million(12M period)
Top 10**
Country Cases Rate
India 53772 40.61
Ukraine 13357 300.57
Nigeria 8634 46.42
Philippines 7476 72.36
Indonesia 6345 24.30
Pakistan 5241 27.13
Serbia 5033 570.63
China 4653 3.32
Italy 4034 67.88
DR Congo 3710 47.12
Other countries with
high incidence rates***
Country Cases Rate
Greece 2752 246.07
Liberia 892 193.33
Georgia 758 193.10
Romania 2129 107.64
Yemen 2371 85.95
Malaysia 2464 79.01
Lebanon 415 69.09
Notes: Based on data received 2018-06 and covering the period between 2017-05 and 2018-04 - Incidence: Number of cases / population* *
100,000 - * World population prospects, 2017 revision - ** Countries with the highest number of cases for the period - *** Countries with the
highest incidence rates (excluding those already listed in the table above)
Measles cases from countries with known discrepancies between case-based and aggregate surveillance, as reported by country
Country Year Cases Data Source
DR Congo 2017 45,165SITUATION EPIDEMIOLOGIQUE DE LA ROUGEOLE EN RDC, Week of 5/6/2018
2018 11,604
Somalia 2017 23,353Somali EPI/POL Weekly Update Week 23, 2018
2018 6021
Number of Reported Measles Cases(6M period)
Top 10*
Country Cases
India 34758
Ukraine 11148
Philippines 6402
Serbia 5015
Nigeria 3587
DR Congo 2604
Greece 2335
China 2271
France 2194
Indonesia 1846
Notes: Based on data received 2018-06 - Surveillance data from 2017-11 to 2018-04 - * Countries with highest number of cases for the period
Measles case distribution (AFR), 2014-2018
20
14
-01
20
14
-02
20
14
-03
20
14
-04
20
14
-05
20
14
-06
20
14
-07
20
14
-08
20
14
-09
20
14
-10
20
14
-11
20
14
-12
20
15
-01
20
15
-02
20
15
-03
20
15
-04
20
15
-05
20
15
-06
20
15
-07
20
15
-08
20
15
-09
20
15
-10
20
15
-11
20
15
-12
20
16
-01
20
16
-02
20
16
-03
20
16
-04
20
16
-05
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
0
2000
4000
6000
8000
Month of onset
Nu
mb
er o
f m
eas
les
case
s
Uganda
OthersNigeriaNiger
LiberiaGabon
EthiopiaEquatorial GuineaDR Congo
CameroonAngola
Notes: Based on data received 2018-06 - Data Source: IVB Database
DRC has experienced a nationwide epidemic that has affected all Provinces, however, only a small proportion of the measles cases in the IDSR
aggregate reporting system are reflected in the case based data. As of 27 May 2013, South Sudan has reassigned to the Africa region (AFR)
from the Eastern Mediterranean region (EMR). For data presentation and statistical purposes, South Sudan data is presented in AFR for all the
years.
Disclaimer
This document contains data provided to WHO by member states. Note that some member states only
provide aggregate data to WHO, and for these, we are unable to generate a country profile. Some
member states report all cases at one time point for the entire year, and thus epidemiologic curves
generated are not accurate and a reporting artifact. For some countries, cases are reported by age
category, not by exact age in months and/or years. Thus, age distribution/incidence is approximate.
Cases classified as pending by countries are classified at WHO as clinically compatible at this time, and
thus numbers might different between data shown here and provided by the member state or WHO
country/regional offices.
*UN population data is used as the denominator for calculating incidence.
Measles cases: Burkina Faso
0
100
200
300
4002
01
6-0
4
20
16
-05
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
0
50
100
150
200
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Burkina Faso age distribution, vaccination status, and incidence, 2017-04 to 2018-03
0
20
40
6080
100
120
Inci
den
ce r
ate
per
1,0
00
,00
0
108.5
77.3
40.3
15.329.6 24.7
9.3
YearConfirmed
Cases
2006 130
2007 11
2008 355
2009 823
2010 398
2011 289
2012 803
2013 422
2014 419
2015 99
2016 223
2017 45
2018 596
Measles cases: Benin
0
100
200
20
16
-05
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
0
50
100
150
200
250
300
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Benin age distribution, vaccination status, and incidence, 2017-05 to 2018-04
0
50
100
150
200
Inci
den
ce r
ate
per
1,0
00
,00
0
126.9
179.1
74.8
20.7 13.8 4.7 1.5
YearConfirmed
Cases
2006 223
2007 351
2008 680
2009 914
2010 246
2011 423
2012 285
2013 757
2014 761
2015 53
2016 98
2017 192
2018 374
Measles cases: Democratic Republic of the Congo
0
1000
2000
3000
40002
01
6-0
5
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
Rollover-Nat (6-59 M)
Cov: 102%
Sub-national (6-59 M)
Cov: 99.5%
Sub-national (6-59 M)
Cov: 103.5%
National SIA Sub-national SIA
0
500
1000
1500
2000
2500
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Democratic Republic of the Congo age distribution, vaccination status, and incidence, 2017-05 to 2018-04
0
50
100
150
200
Inci
den
ce r
ate
per
1,0
00
,00
0
164191.5
69.1
15.8 7.1 3.8 0.6
YearConfirmed
Cases
2006 1012
2007 539
2008 214
2009 83
2010 208
2011 1651
2012 2332
2013 2527
2014 1649
2015 5029
2016 4932
2017 3597
2018 2459
Measles cases: Ethiopia
0
200
400
600
20
16
-05
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
Sub-national (9 M-14 Y)
Cov: 96.3%
Sub-national (6-179 M)
Cov: 98%
National SIA Sub-national SIA
0
100
200
300
400
500
600
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Ethiopia age distribution, vaccination status, and incidence, 2017-05 to 2018-04
0
10
20
Inci
den
ce r
ate
per
1,0
00
,00
0
21.423.4
17.7
13.4
24
6.2
0.5
YearConfirmed
Cases
2006 1278
2007 1472
2008 3161
2009 2642
2010 6205
2011 3552
2012 4616
2013 6137
2014 14282
2015 17778
2016 4568
2017 1912
2018 547
Measles cases: Guinea
0
100
200
300
20
16
-05
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
NA (6-59 M)
National SIA Sub-national SIA
0
100
200
300
400
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Guinea age distribution, vaccination status, and incidence, 2017-05 to 2018-04
0
50
100
150
200
250
Inci
den
ce r
ate
per
1,0
00
,00
0
181.7
223.5
54.3
13.6 6.8 4.5 0.4
YearConfirmed
Cases
2006 2
2007 6
2008 92
2009 216
2010 58
2011 20
2012 14
2013 59
2014 216
2015 29
2016 334
2017 596
2018 364
Measles cases: Nigeria
0
1000
2000
30002
01
6-0
5
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
Sub-national (6 M-10 Y) NA (9-59 M)
National SIA Sub-national SIA
0
2000
4000
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Nigeria age distribution, vaccination status, and incidence, 2017-05 to 2018-04
0
50
100
150
200
Inci
den
ce r
ate
per
1,0
00
,00
0
108.1
181.4
74.7
26.612.1 9.5 4.3
YearConfirmed
Cases
2006 1019
2007 3129
2008 10453
2009 1498
2010 9072
2011 19062
2012 6423
2013 55392
2014 6850
2015 12391
2016 17581
2017 11188
2018 3310
Measles cases: Uganda
0
100
200
300
400
500
6002
01
6-0
5
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
0
200
400
600
800
1000
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Uganda age distribution, vaccination status, and incidence, 2017-05 to 2018-04
0
50
100
150
Inci
den
ce r
ate
per
1,0
00
,00
0
159.4 155.5
74
32.59.2 2.5 1
YearConfirmed
Cases
2006 1035
2007 291
2008 115
2009 86
2010 41
2011 132
2012 720
2013 460
2014 315
2015 466
2016 252
2017 892
2018 1157
Measles case distribution (AMR), 2014-2018
20
14
-01
20
14
-02
20
14
-03
20
14
-04
20
14
-05
20
14
-06
20
14
-07
20
14
-08
20
14
-09
20
14
-10
20
14
-11
20
14
-12
20
15
-01
20
15
-02
20
15
-03
20
15
-04
20
15
-05
20
15
-06
20
15
-07
20
15
-08
20
15
-09
20
15
-10
20
15
-11
20
15
-12
20
16
-01
20
16
-02
20
16
-03
20
16
-04
20
16
-05
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
0
100
200
300
400
500
600
700
800
900
1000
1100
1200
Month of onset
Nu
mb
er o
f m
eas
les
case
s
Venezuela (Bolivarian Republic of)
USAPeruOthersMexicoEcuador
ColombiaChileCanadaBrazilArgentina
Notes: Based on data received 2018-06 - Data Source: IVB Database, VEN data for May 2018 is an aggregate sum for all 2018 cases and is an
artifact of reporting.
Measles cases: Venezuela (Bolivarian Republic of)
0
200
400
600
800
10002
01
6-0
5
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
0
100
200
300
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Venezuela (Bolivarian Republic of) age distribution, vaccination status, and incidence, 2017-05 to 2018-04
0
100
200
300
400
Inci
den
ce r
ate
per
1,0
00
,00
0
344.8
131.7
49.3 39.58.9 3.2 1.4
YearConfirmed
Cases
2008 0
2009 0
2010 0
2011 0
2012 1
2013 0
2014 0
2015 0
2016 3
2017 727
2018 904
Note: 2018 cases are artificially lumped as
having date of onset of May 2018 due to an
artifact of reporting by the country.
Measles case distribution (EMR), 2014-2018
20
14
-01
20
14
-02
20
14
-03
20
14
-04
20
14
-05
20
14
-06
20
14
-07
20
14
-08
20
14
-09
20
14
-10
20
14
-11
20
14
-12
20
15
-01
20
15
-02
20
15
-03
20
15
-04
20
15
-05
20
15
-06
20
15
-07
20
15
-08
20
15
-09
20
15
-10
20
15
-11
20
15
-12
20
16
-01
20
16
-02
20
16
-03
20
16
-04
20
16
-05
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
0
500
1000
1500
2000
2500
3000
Month of onset
Nu
mb
er o
f m
eas
les
case
s
YemenUnited Arab EmiratesSyrian Arab Republic
SudanSomaliaSaudi Arabia
PakistanOthersIraqEgyptAfghanistan
Notes: Based on data received 2018-06 - Data Source: IVB Database
Measles cases: Afghanistan
0
100
200
300
400
500
6002
01
6-0
4
20
16
-05
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
Sub-national (9 M-10 Y)
Cov: 105%
National SIA Sub-national SIA
0
200
400
600
800
1000
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Afghanistan age distribution, vaccination status, and incidence, 2017-04 to 2018-03
0
100
200
300
400
500
Inci
den
ce r
ate
per
1,0
00
,00
0
478.2
235.7
60.621 8.9 4.5 0.2
YearConfirmed
Cases
2006 4458
2007 982
2008 1189
2009 2873
2010 1989
2011 1384
2012 2671
2013 430
2014 552
2015 1185
2016 641
2017 1511
2018 1013
Measles cases: Pakistan
0
500
1000
1500
20
16
-05
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
0
2000
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Pakistan age distribution, vaccination status, and incidence, 2017-05 to 2018-04
0
50
100
150
200
250
Inci
den
ce r
ate
per
1,0
00
,00
0
215
156.4
35.76.2 1.1 0.4 0
YearConfirmed
Cases
2006 35
2007 33
2008 53
2009 472
2010 1111
2011 2676
2012 8048
2013 8030
2014 1370
2015 1117
2016 2806
2017 6780
2018 670
Measles cases: Yemen
0
200
400
600
8002
01
6-0
4
20
16
-05
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
0200400600800
100012001400
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Yemen age distribution, vaccination status, and incidence, 2017-04 to 2018-03
0100200300400500600
Inci
den
ce r
ate
per
1,0
00
,00
0
557.5
371.4
167.6
42.6 8.1 7.6 0.7
YearConfirmed
Cases
2006 4989
2007 50
2008 53
2009 127
2010 372
2011 847
2012 2143
2013 571
2014 817
2015 465
2016 143
2017 2101
2018 736
Measles case distribution (EUR), 2014-2018
20
14
-01
20
14
-02
20
14
-03
20
14
-04
20
14
-05
20
14
-06
20
14
-07
20
14
-08
20
14
-09
20
14
-10
20
14
-11
20
14
-12
20
15
-01
20
15
-02
20
15
-03
20
15
-04
20
15
-05
20
15
-06
20
15
-07
20
15
-08
20
15
-09
20
15
-10
20
15
-11
20
15
-12
20
16
-01
20
16
-02
20
16
-03
20
16
-04
20
16
-05
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
0
1000
2000
3000
4000
5000
6000
7000
Month of onset
Nu
mb
er o
f m
eas
les
case
s
UkraineSerbiaRussian FederationRomaniaOthersKyrgyzstan
ItalyGermanyGeorgia
FranceBosnia and Herzegovina
Notes: Based on data received 2018-06 - Data Source: IVB Database
Measles cases: France
0
200
400
600
8002
01
6-0
5
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
0
200
400
600
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
France age distribution, vaccination status, and incidence, 2017-05 to 2018-04
0
50
100
150
200
250
300
Inci
den
ce r
ate
per
1,0
00
,00
0
256.4
156.3
61.7 65.2 77.943.8
4.3
YearConfirmed
Cases
2006 16
2007 40
2008 606
2009 1541
2010 5019
2011 15214
2012 859
2013 272
2014 267
2015 373
2016 79
2017 519
2018 2118
Measles cases: Georgia
0
100
200
300
20
16
-05
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
0
50
100
150
200
250
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Georgia age distribution, vaccination status, and incidence, 2017-05 to 2018-04
0
500
1000
1500
2000
Inci
den
ce r
ate
per
1,0
00
,00
0
1762.8
537.4301.9 416.3
219.7 264.320.5
YearConfirmed
Cases
2006 8
2007 2
2008 55
2009 23
2010 22
2011 64
2012 30
2013 7868
2014 3190
2015 430
2016 14
2017 96
2018 664
Measles cases: Greece
0
100
200
300
400
5002
01
6-0
5
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
0
200
400
600
800
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Greece age distribution, vaccination status, and incidence, 2017-05 to 2018-04
0
1000
2000
3000
4000
Inci
den
ce r
ate
per
1,0
00
,00
0
3438.2
1582.1
947.3515.8
231.9 200.3 43.5
YearConfirmed
Cases
2006 215
2007 1
2008 1
2009 2
2010 149
2011 40
2012 3
2013 2
2014 1
2015 1
2016 0
2017 1066
2018 1686
Measles cases: Russian Federation
0
100
200
300
4002
01
6-0
5
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
0
100
200
300
400
500
600
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Russian Federation age distribution, vaccination status, and incidence, 2017-05 to 2018-04
020406080100120
Inci
den
ce r
ate
per
1,0
00
,00
0
113.9
73.4
20.210.5 11.1 9.6 2.5
YearConfirmed
Cases
2006 1129
2007 172
2008 27
2009 101
2010 152
2011 783
2012 1975
2013 2501
2014 3263
2015 635
2016 179
2017 874
2018 855
Measles cases: Serbia
0
500
1000
1500
20
16
-05
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
0
2000
<1 year 1-4 years 5-9 years 10-14 years 15-19 years 20-29 years 30+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Serbia age distribution, vaccination status, and incidence, 2017-05 to 2018-04
0
1000
2000
3000
4000
5000
Inci
den
ce r
ate
per
1,0
00
,00
0
4721.4
2178.5
460.1 277.6 203.9 372.3 570.6
YearConfirmed
Cases
2006 0
2007 147
2008 2
2009 1
2010 8
2011 358
2012 0
2013 1
2014 35
2015 368
2016 14
2017 702
2018 4337
Measles cases: Ukraine
0
1000
2000
3000
20
16
-05
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
0
2000
<1 year 1-4 years 5-9 years 10-14 years 15-19 years 20-29 years 30+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Ukraine age distribution, vaccination status, and incidence, 2017-05 to 2018-04
0
500
1000
1500
2000
Inci
den
ce r
ate
per
1,0
00
,00
0
1819.9
1475.8
1150.7
788.3
300.9179.5 87.6
YearConfirmed
Cases
2006 945
2007 232
2008 41
2009 24
2010 42
2011 1313
2012 12744
2013 3308
2014 2326
2015 141
2016 90
2017 4782
2018 8747
Measles case distribution (SEAR (excl. India)), 2014-2018
20
14
-01
20
14
-02
20
14
-03
20
14
-04
20
14
-05
20
14
-06
20
14
-07
20
14
-08
20
14
-09
20
14
-10
20
14
-11
20
14
-12
20
15
-01
20
15
-02
20
15
-03
20
15
-04
20
15
-05
20
15
-06
20
15
-07
20
15
-08
20
15
-09
20
15
-10
20
15
-11
20
15
-12
20
16
-01
20
16
-02
20
16
-03
20
16
-04
20
16
-05
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
0
500
1000
1500
2000
2500
3000
3500
Month of onset
Nu
mb
er o
f m
eas
les
case
s
Timor-LesteThailandSri LankaNepalMyanmar
MaldivesIndonesiaDPR KoreaBhutanBangladesh
Notes: Based on data received 2018-06 - Data Source: IVB Database
Measles cases: Indonesia
0
2000
4000
60002
01
6-0
5
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
Sub-national (9-59 M)
Cov: 86%
Sub-national (9 M-15 Y)
Cov: 100.5%
National SIA Sub-national SIA
0
200
400
600
800
1000
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Indonesia age distribution, vaccination status, and incidence, 2017-05 to 2018-04
0
20
40
Inci
den
ce r
ate
per
1,0
00
,00
0
24.8
36.4 36
17.2
7.82.1 0.1
YearConfirmed
Cases
2006 21911
2007 20837
2008 16417
2009 21008
2010 23471
2011 23510
2012 16786
2013 10093
2014 9498
2015 6209
2016 7204
2017 11389
2018 1187
Measles case distribution (SEAR, India), 2014-2018
20
14
-01
20
14
-02
20
14
-03
20
14
-04
20
14
-05
20
14
-06
20
14
-07
20
14
-08
20
14
-09
20
14
-10
20
14
-11
20
14
-12
20
15
-01
20
15
-02
20
15
-03
20
15
-04
20
15
-05
20
15
-06
20
15
-07
20
15
-08
20
15
-09
20
15
-10
20
15
-11
20
15
-12
20
16
-01
20
16
-02
20
16
-03
20
16
-04
20
16
-05
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
0
5000
10000
15000
Month of onset
Nu
mb
er o
f m
eas
les
case
s
India
Notes: Based on data received 2018-06 - Data Source: IVB Database
Measles cases: India
0
5000
10000
15000
20000
250002
01
6-0
5
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
Rollover-Nat (9 M-15 Y)
National SIA Sub-national SIA
0
2000
4000
6000
8000
10000
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
India age distribution, vaccination status, and incidence, 2017-05 to 2018-04
0
20
40
60
80
100
Inci
den
ce r
ate
per
1,0
00
,00
0
78.485.3
73
20.3
3.6 1.1 0.2
YearConfirmed
Cases
2014 80306
2015 83026
2016 70798
2017 56302
2018 28691
Measles case distribution (WPR), 2014-2018
20
14
-01
20
14
-02
20
14
-03
20
14
-04
20
14
-05
20
14
-06
20
14
-07
20
14
-08
20
14
-09
20
14
-10
20
14
-11
20
14
-12
20
15
-01
20
15
-02
20
15
-03
20
15
-04
20
15
-05
20
15
-06
20
15
-07
20
15
-08
20
15
-09
20
15
-10
20
15
-11
20
15
-12
20
16
-01
20
16
-02
20
16
-03
20
16
-04
20
16
-05
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
0
2000
4000
6000
8000
10000
12000
14000
16000
18000
20000
22000
Month of onset
Nu
mb
er o
f m
eas
les
case
s
Viet NamSingaporeRepublic of KoreaPhilippinesPapua New Guinea
Others
MongoliaMalaysiaJapan
ChinaAustralia
Notes: Based on data received 2018-06 - Data Source: IVB Database
Measles cases: Philippines
0
1000
2000
20
16
-05
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
DiscardedClinicalEpi
Lab Month of onset
Nu
mb
er o
f ca
ses
0
2000
<1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years
0 doses 1 dose 2+ doses Unknown
Age at onset
Nu
mb
er o
f ca
ses
Philippines age distribution, vaccination status, and incidence, 2017-05 to 2018-04
0
200
400
600
800
1000
Inci
den
ce r
ate
per
1,0
00
,00
0
938.7
316.8
55 23.7 46.7 25.7 3.8
YearConfirmed
Cases
2006 216
2007 612
2008 838
2009 1351
2010 6363
2011 6519
2012 1441
2013 4855
2014 53906
2015 2021
2016 647
2017 1606
2018 6178
Distribution of measles genotypes(last 12 months)
Notes: Data Source: MeaNS database (Genotypes) and IVB Database (Incidence) as of 2018-06-07 and covering the period 2017-05-01 to
2018-04-30 - Pie charts proportional to the number of sequenced viruses
Rubella
Number of Reported Rubella Cases by WHO Regions
2018
RegionMember States*
Rubella cases
Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov DecDate
Received
AFR 40/47 1376 0 0 1376 308 244 464 281 79 0 0 0 0 0 0 0 2018-06
AMR 23/35 1 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 2018-06
EMR 19/21 247 4 0 243 64 87 90 6 0 0 0 0 0 0 0 0 2018-06
EUR 26/53 227 195 1 31 52 54 57 64 0 0 0 0 0 0 0 0 2018-06
SEAR 11/11 884 0 45 839 224 245 263 130 22 0 0 0 0 0 0 0 2018-06
WPR 14/27 887 105 8 774 111 98 260 418 0 0 0 0 0 0 0 0 2018-06
Total 133/194 3622 304 54 3264 759 729 1134 899 101 0 0 0 0 0 0 0
2017
RegionMember States*
Rubella cases
Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov DecDate
Received
AFR 42/47 4569 0 0 4569 278 515 586 328 343 372 212 331 388 647 459 110 2018-06
AMR 26/35 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2018-06
EMR 20/21 914 43 1 870 76 111 121 106 156 112 49 22 25 50 47 39 2018-06
EUR 29/53 702 568 17 117 58 60 87 69 85 58 54 47 38 54 46 46 2018-06
SEAR 11/11 7634 0 2252 5382 582 1098 1571 1241 798 357 325 510 339 358 249 206 2018-06
WPR 14/27 2283 258 162 1863 153 201 342 308 295 194 195 129 115 81 108 162 2018-06
Total 142/194 16102 869 2432 12801 1147 1985 2707 2052 1677 1093 835 1039 905 1190 909 563
Notes: Based on data received 2018-06 - This is surveillance data, hence for the last month, the data may be incomplete. * Member States
Reporting / Total Member States in Region
Rubella Case Distribution by Month and WHO Region (2015-2018)
20
15
-01
20
15
-02
20
15
-03
20
15
-04
20
15
-05
20
15
-06
20
15
-07
20
15
-08
20
15
-09
20
15
-10
20
15
-11
20
15
-12
20
16
-01
20
16
-02
20
16
-03
20
16
-04
20
16
-05
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
0
500
1000
1500
2000
2500
3000
3500
4000
4500
5000
5500
Month of onset
Ru
bel
la c
ases
(La
b+E
pi+
Clin
ical
)
WPRSEAREUREMRAMRAFR
Notes: Based on data received 2018-06 - Data Source: IVB Database - This is surveillance data, hence for the last month(s), the
data may be incomplete.
Rubella cases: AFR
0
200
400
6002
01
6-0
5
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
Not introduced in EPIIntroduced <5 years ago (after 2012)
Introduced >=5 years ago (2012 and before)
Month of onset
Nu
mb
er
of
case
s(I
gM+
on
ly)
AFR Rubella Case Distribution (June 2016-May 2018)
0
200
400
600
0 1 2 3 4 5 6 7 8 91
01
11
21
31
41
51
61
71
81
92
02
12
22
32
42
52
62
72
82
93
03
13
23
33
43
53
63
73
83
94
04
14
24
34
44
54
6
Rubella vaccine not introduced before 1 January 2017 Rubella vaccine introduced before 1 January 2017
Age at onset (in years)
Nu
mb
er o
f ca
ses
(IgM
+ o
nly
)
AFR Age distribution of Rubella IgM+ cases by vaccine introduction status in the National EPI Programme (June 2017-May 2018)
Top 10 countries (last 12 M)
labelRCV in
RICases
% of Total
South Africa No 1507 39
Ethiopia No 560 14
DR Congo No 536 14
Others - 323 8
Uganda No 292 7
Nigeria No 216 6
Cote d'Ivoire No 183 5
Madagascar No 93 2
Mali No 79 2
South Sudan No 58 1
Mozambique 2017 48 1
Notes: Based on data received 2018-06 Data Source: IVB Database. RCV in RI: Rubella-containing vaccine in Routine Immunization as of 31
Dec 2016.
Rubella cases: EMR
0
100
200
3002
01
6-0
5
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
Not introduced in EPIIntroduced <5 years ago (after 2012)
Introduced >=5 years ago (2012 and before)
Month of onset
Nu
mb
er
of
case
s(l
ab +
ep
i-lin
ked
+ c
linic
al)
EMR Rubella Case Distribution (June 2016-May 2018)
0102030405060708090
0 1 2 3 4 5 6 7 8 91
01
11
21
31
41
51
61
71
81
92
02
12
22
32
42
52
62
72
82
93
03
13
23
33
43
53
63
73
83
94
04
14
24
34
44
54
6
Rubella vaccine not introduced before 1 January 2017 Rubella vaccine introduced before 1 January 2017
Age at onset (in years)
Nu
mb
er o
f ca
ses
(lab
+ e
pi-
linke
d +
clin
ical
) EMR Age distribution of Rubella cases by vaccine introduction status in the National EPI Programme (June 2017-May 2018)
Top 10 countries (last 12 M)
labelRCV in
RICases
% of Total
Sudan No 221 37
Pakistan No 196 33
Saudi Arabia 1991 35 6
Afghanistan No 32 5
Iran (Islamic Republic of)
2004 23 4
Others - 23 4
United Arab Emirates
1985 21 4
Egypt 1999 16 3
Lebanon 1995 11 2
Tunisia 2004 8 1
Morocco 2014 5 1
Notes: Based on data received 2018-06 Data Source: IVB Database. RCV in RI: Rubella-containing vaccine in Routine Immunization as of 31
Dec 2016.
Rubella cases: EUR
0
50
100
1502
01
6-0
5
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
Not introduced in EPIIntroduced <5 years ago (after 2012)
Introduced >=5 years ago (2012 and before)
Month of onset
Nu
mb
er
of
case
s(l
ab +
ep
i-lin
ked
+ c
linic
al)
EUR Rubella Case Distribution (June 2016-May 2018)
0
50
100
150
0 1 2 3 4 5 6 7 8 91
01
11
21
31
41
51
61
71
81
92
02
12
22
32
42
52
62
72
82
93
03
13
23
33
43
53
63
73
83
94
04
14
24
34
44
54
6
Rubella vaccine not introduced before 1 January 2017 Rubella vaccine introduced before 1 January 2017
Age at onset (in years)
Nu
mb
er o
f ca
ses
(lab
+ e
pi-
linke
d +
clin
ical
) EUR Age distribution of Rubella cases by vaccine introduction status in the National EPI Programme (June 2017-May 2018)
Top 10 countries (last 12 M)
labelRCV in
RICases
% of Total
Poland 1988 423 74
Germany 1991 56 10
Italy 1972 28 5
Austria 1973 20 4
Others - 15 3
Turkey 2006 9 2
Romania 2002 6 1
Kyrgyzstan 2001 4 1
Georgia 2004 3 1
Portugal 1984 3 1
United Kingdom of Great Britain
and Northern Ireland
1970 3 1
Notes: Based on data received 2018-06 Data Source: IVB Database. RCV in RI: Rubella-containing vaccine in Routine Immunization as of 31
Dec 2016. Spikes in age-distribution curve are an artifact of reporting by age bands ( 0=<1 yrs, 2=1-4 yrs, 7=5-9 yrs, 12=10-14 yrs, 17=15-19
yrs, 25=20-29 yrs, 45=30+yrs) instead of by age from some member states.
Rubella cases: SEAR (excl. India)
0
200
400
6002
01
6-0
5
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
Not introduced in EPIIntroduced <5 years ago (after 2012)
Introduced >=5 years ago (2012 and before)
Month of onset
Nu
mb
er
of
case
s(l
ab +
ep
i-lin
ked
+ c
linic
al)
SEAR (excl. India) Rubella Case Distribution (June 2016-May 2018)
0
100
200
0 1 2 3 4 5 6 7 8 91
01
11
21
31
41
51
61
71
81
92
02
12
22
32
42
52
62
72
82
93
03
13
23
33
43
53
63
73
83
94
04
14
24
34
44
54
6
Rubella vaccine not introduced before 1 January 2017 Rubella vaccine introduced before 1 January 2017
Age at onset (in years)
Nu
mb
er o
f ca
ses
(lab
+ e
pi-
linke
d +
clin
ical
) SEAR (excl. India) Age distribution of Rubella cases by vaccine introduction status in the National EPI Programme (June 2017-May 2018)
Top 10 countries (last 12 M)
labelRCV in
RICases
% of Total
Indonesia No 2374 87
Bangladesh 2012 309 11
Nepal 2013 22 1
Thailand 1993 17 1
Timor-Leste 2016 7 0
Myanmar 2015 6 0
Bhutan 2006 4 0
Sri Lanka 1996 1 0
Notes: Based on data received 2018-06 Data Source: IVB Database. RCV in RI: Rubella-containing vaccine in Routine Immunization as of 31
Dec 2016.
Rubella cases: SEAR, India
0
200
400
600
800
10002
01
6-0
5
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
Not introduced in EPIIntroduced <5 years ago (after 2012)
Introduced >=5 years ago (2012 and before)
Month of onset
Nu
mb
er
of
case
s(l
ab +
ep
i-lin
ked
+ c
linic
al)
SEAR, India Rubella Case Distribution (June 2016-May 2018)
010203040506070
0 1 2 3 4 5 6 7 8 91
01
11
21
31
41
51
61
71
81
92
02
12
22
32
42
52
62
72
82
93
03
13
23
33
43
53
63
73
83
94
04
14
24
34
44
54
6
Rubella vaccine not introduced before 1 January 2017 Rubella vaccine introduced before 1 January 2017
Age at onset (in years)
Nu
mb
er o
f ca
ses
(lab
+ e
pi-
linke
d +
clin
ical
) SEAR, India Age distribution of Rubella cases by vaccine introduction status in the National EPI Programme (June 2017-May 2018)
Top 10 countries (last 12 M)
labelRCV in
RICases
% of Total
India No 488 100
Notes: Based on data received 2018-06 Data Source: IVB Database. RCV in RI: Rubella-containing vaccine in Routine Immunization as of 31
Dec 2016.
Rubella cases: WPR
0
1000
20002
01
6-0
5
20
16
-06
20
16
-07
20
16
-08
20
16
-09
20
16
-10
20
16
-11
20
16
-12
20
17
-01
20
17
-02
20
17
-03
20
17
-04
20
17
-05
20
17
-06
20
17
-07
20
17
-08
20
17
-09
20
17
-10
20
17
-11
20
17
-12
20
18
-01
20
18
-02
20
18
-03
20
18
-04
20
18
-05
20
18
-06
Not introduced in EPIIntroduced <5 years ago (after 2012)
Introduced >=5 years ago (2012 and before)
Month of onset
Nu
mb
er
of
case
s(l
ab +
ep
i-lin
ked
+ c
linic
al)
WPR Rubella Case Distribution (June 2016-May 2018)
020406080
100120
0 1 2 3 4 5 6 7 8 91
01
11
21
31
41
51
61
71
81
92
02
12
22
32
42
52
62
72
82
93
03
13
23
33
43
53
63
73
83
94
04
14
24
34
44
54
6
Rubella vaccine not introduced before 1 January 2017 Rubella vaccine introduced before 1 January 2017
Age at onset (in years)
Nu
mb
er o
f ca
ses
(lab
+ e
pi-
linke
d +
clin
ical
) WPR (Excl. China) Age distribution of Rubella cases by vaccine introduction status in the National EPI Programme (June 2017-May 2018)
Top 10 countries (last 12 M)
labelRCV in
RICases
% of Total
China 2008 1469 79
Philippines 2010 221 12
Malaysia 1998 99 5
Viet Nam 2015 69 4
Cambodia 2013 2 0
Fiji 1995 2 0
Japan 1989 2 0
Others - 2 0
Papua New Guinea
2015 2 0
Singapore 1990 2 0
Republic of Korea 1982 1 0
Notes: Based on data received 2018-06 Data Source: IVB Database. RCV in RI: Rubella-containing vaccine in Routine Immunization as of 31
Dec 2016.
Distribution of rubella genotypes(last 12 months)
Notes: Data Source: RubNS database (Genotypes) and IVB Database (Incidence) as of 2018-06-07 and covering the period 2017-05-01 to
2018-04-30 - Pie charts proportional to the number of sequenced viruses
Laboratory
Measles and Rubella IgM Data Summary
2017
RegionMember States*
Specimens received
Measles tested
Measles positive n(%)
Measles equivocal n(%)
Measles negative n(%)
Rubella tested
Rubella positive n(%)
Rubella equivocal n(%)
Rubella negative n(%)
AFR 39/47 35241 35241 4623 (13) 666 (2) 29952 (85) 29671 4964 (17) 1264 (4) 23443 (79)
AMR 27/35 9066 8732 621 (7) 58 (1) 7439 (85) 7934 330 (4) 107 (1) 6907 (87)
EMR 20/21 36248 34779 10560 (30) 127 (0) 24092 (69) 32724 1105 (3) 99 (0) 31520 (96)
EUR 38/53 42296 37038 13612 (37) 272 (1) 22624 (61) 26322 434 (2) 66 (0) 25736 (98)
SEAR 11/11 35379 32335 13177 (41) 781 (2) 20062 (62) 20383 4831 (24) 741 (4) 14804 (73)
WPR 27/27 16467 15211 2100 (14) 333 (2) 11952 (79) 12656 606 (5) 418 (3) 10748 (85)
Total 162/194 174697 163336 44693 (27) 2237 (1) 116121 (71) 129690 12270 (9) 2695 (2) 113158 (87)
2018
RegionMember States*
Specimens received
Measles tested
Measles positive n(%)
Measles equivocal n(%)
Measles negative n(%)
Rubella tested
Rubella positive n(%)
Rubella equivocal n(%)
Rubella negative n(%)
AFR 35/47 9640 9640 2058 (21) 232 (2) 7350 (76) 6914 1178 (17) 401 (6) 5335 (77)
AMR 26/35 5720 5387 304 (6) 48 (1) 4748 (88) 4990 223 (4) 124 (2) 4346 (87)
EMR 20/21 9527 8936 2934 (33) 14 (0) 5988 (67) 7432 326 (4) 27 (0) 7079 (95)
EUR 36/53 23068 21333 6975 (33) 149 (1) 14045 (66) 11411 254 (2) 19 (0) 11119 (97)
SEAR 11/11 10203 7125 2754 (39) 226 (3) 4141 (58) 4651 841 (18) 148 (3) 3658 (79)
WPR 27/27 9159 8525 1605 (19) 173 (2) 4280 (50) 6725 181 (3) 109 (2) 3258 (48)
Total 155/194 67317 60946 16630 (27) 842 (1) 40552 (67) 42123 3003 (7) 828 (2) 34795 (83)
Notes: Based on data received 2018-06 - * Member States Reporting / Total Member States in Region
Performance of Surveillance
Surveillance sensitivity reporting rate of measles and rubella (12 months, discarded cases* per 100,000 population)
Notes: Based on data received 2018-06 and covering the period between 2017-05 and 2018-04 - Target: >= 2 discarded cases* / 100,000
population** - * Suspected cases investigated and discarded as non-measles non-rubella using laboratory testing and/or epidemiological linkage
to another etiology ** World population prospects, 2017 revision
Supplementary Immunization Activities
Next 6 months MMR, MR and Measles campaigns
Region Name Activity Type Year StartDate EndDateAge
Group(s)Extent Target
SEAR Timor-Leste FollowUp MR 2018 2018-07-01 - 9-59 M National 170000
EMR Afghanistan FollowUp Measles 2018 2018-08-01 - 9-59 M National 5939071
SEAR Indonesia CatchUp MR 2018 2018-08-01 2018-09-30 9 M-15 Y Rollover-Nat 3.4e+07
AFR Ghana FollowUp MR 2018 2018-10-01 - 9-59 M National 4650610
EMR Djibouti FollowUp Measles 2018 2018-11-01 - 9-59 M National 101885
SEAR India CatchUp MR 2018 2018-11-01 2018-12-31 9 M-15 Y Rollover-Nat 119400000
SEAR Bhutan CatchUp MR 2018 2018-12-01 - 9 M-40 Y Sub-national 1e+05
Link to global Measles SurveillanceHQ website
• AFR Monthly feedback tables
• AMR: Weekly bulletin (published every Friday)
• EMR: Home page
• EUR : Periodical bulletin
Monthly data
• SEAR: Monthly bulletin
EPI country fact sheets
• WPR: Periodical newsletter
Country profiles
(Switch to presentation mode if links are inactive)
Regional Bulletins and Newsletters